UBS raises Jazz Pharmaceuticals price target to $337
UBS raised its price target on Jazz Pharmaceuticals to $337.00 per share from $315.00, while maintaining a Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.